These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19. Parums DV Med Sci Monit; 2021 Sep; 27():e934766. PubMed ID: 34538868 [TBL] [Abstract][Full Text] [Related]
45. Examination of autoantibodies to type I interferon in patients suffering from long COVID. Hansen KS; Jørgensen SE; Skouboe MK; Agergaard J; Schiøttz-Christensen B; Vibholm LK; Tolstrup M; Østergaard L; Leth S; Mogensen TH J Med Virol; 2023 Sep; 95(9):e29089. PubMed ID: 37698062 [TBL] [Abstract][Full Text] [Related]
46. Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease. Samuel CE J Biol Chem; 2023 Aug; 299(8):104960. PubMed ID: 37364688 [TBL] [Abstract][Full Text] [Related]
47. Autoantibodies against type I IFNs in patients with critical influenza pneumonia. Zhang Q; Pizzorno A; Miorin L; Bastard P; Gervais A; Le Voyer T; Bizien L; Manry J; Rosain J; Philippot Q; Goavec K; Padey B; Cupic A; Laurent E; Saker K; Vanker M; Särekannu K; ; ; ; ; ; ; ; García-Salum T; Ferres M; Le Corre N; Sánchez-Céspedes J; Balsera-Manzanero M; Carratala J; Retamar-Gentil P; Abelenda-Alonso G; Valiente A; Tiberghien P; Zins M; Debette S; Meyts I; Haerynck F; Castagnoli R; Notarangelo LD; Gonzalez-Granado LI; Dominguez-Pinilla N; Andreakos E; Triantafyllia V; Rodríguez-Gallego C; Solé-Violán J; Ruiz-Hernandez JJ; Rodríguez de Castro F; Ferreres J; Briones M; Wauters J; Vanderbeke L; Feys S; Kuo CY; Lei WT; Ku CL; Tal G; Etzioni A; Hanna S; Fournet T; Casalegno JS; Queromes G; Argaud L; Javouhey E; Rosa-Calatrava M; Cordero E; Aydillo T; Medina RA; Kisand K; Puel A; Jouanguy E; Abel L; Cobat A; Trouillet-Assant S; García-Sastre A; Casanova JL J Exp Med; 2022 Nov; 219(11):. PubMed ID: 36112363 [TBL] [Abstract][Full Text] [Related]
49. Severe COVID-19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals. Gray PE; Bartlett AW; Tangye SG Clin Transl Immunology; 2022; 11(4):e1365. PubMed ID: 35444807 [TBL] [Abstract][Full Text] [Related]
50. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. Lopez J; Mommert M; Mouton W; Pizzorno A; Brengel-Pesce K; Mezidi M; Villard M; Lina B; Richard JC; Fassier JB; Cheynet V; Padey B; Duliere V; Julien T; Paul S; Bastard P; Belot A; Bal A; Casanova JL; Rosa-Calatrava M; Morfin F; Walzer T; Trouillet-Assant S J Exp Med; 2021 Oct; 218(10):. PubMed ID: 34357402 [TBL] [Abstract][Full Text] [Related]
51. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine. Bastard P; Michailidis E; Hoffmann HH; Chbihi M; Le Voyer T; Rosain J; Philippot Q; Seeleuthner Y; Gervais A; Materna M; de Oliveira PMN; Maia MLS; Dinis Ano Bom AP; Azamor T; Araújo da Conceição D; Goudouris E; Homma A; Slesak G; Schäfer J; Pulendran B; Miller JD; Huits R; Yang R; Rosen LB; Bizien L; Lorenzo L; Chrabieh M; Erazo LV; Rozenberg F; Jeljeli MM; Béziat V; Holland SM; Cobat A; Notarangelo LD; Su HC; Ahmed R; Puel A; Zhang SY; Abel L; Seligman SJ; Zhang Q; MacDonald MR; Jouanguy E; Rice CM; Casanova JL J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33544838 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of Genetic or Cellular Impairments in Type I IFN Immunity in a Cohort of Young Adults with Critical COVID-19. Covill LE; Sendel A; Campbell TM; Piiroinen I; Enoksson SL; Borgström EW; Hansen S; Ma K; Marits P; Norlin AC; Smith CIE; Kåhlin J; Eriksson LI; Bergman P; Bryceson YT J Clin Immunol; 2024 Jan; 44(2):50. PubMed ID: 38231281 [TBL] [Abstract][Full Text] [Related]
53. Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19. Abers MS; Rosen LB; Delmonte OM; Shaw E; Bastard P; Imberti L; Quaresima V; Biondi A; Bonfanti P; Castagnoli R; Casanova JL; Su HC; Notarangelo LD; Holland SM; Lionakis MS Immunol Cell Biol; 2021 Oct; 99(9):917-921. PubMed ID: 34309902 [TBL] [Abstract][Full Text] [Related]
54. Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies. Damoiseaux J; Dotan A; Fritzler MJ; Bogdanos DP; Meroni PL; Roggenbuck D; Goldman M; Landegren N; Bastard P; Shoenfeld Y; Conrad K Autoimmun Rev; 2022 Mar; 21(3):103012. PubMed ID: 34896650 [TBL] [Abstract][Full Text] [Related]